AU7454598A - Use of drug carriers for producing lymphnode migrating drugs - Google Patents

Use of drug carriers for producing lymphnode migrating drugs

Info

Publication number
AU7454598A
AU7454598A AU74545/98A AU7454598A AU7454598A AU 7454598 A AU7454598 A AU 7454598A AU 74545/98 A AU74545/98 A AU 74545/98A AU 7454598 A AU7454598 A AU 7454598A AU 7454598 A AU7454598 A AU 7454598A
Authority
AU
Australia
Prior art keywords
lymphnode
migrating
drugs
producing
drug carriers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74545/98A
Inventor
Kazutoshi Horie
Kazuyoshi Masuda
Masahiro Sakagami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU7454598A publication Critical patent/AU7454598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU74545/98A 1997-06-03 1998-05-29 Use of drug carriers for producing lymphnode migrating drugs Abandoned AU7454598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14501197 1997-06-03
JP9-145011 1997-06-03
PCT/JP1998/002373 WO1998055149A1 (en) 1997-06-03 1998-05-29 Use of drug carriers for producing lymphnode migrating drugs

Publications (1)

Publication Number Publication Date
AU7454598A true AU7454598A (en) 1998-12-21

Family

ID=15375389

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74545/98A Abandoned AU7454598A (en) 1997-06-03 1998-05-29 Use of drug carriers for producing lymphnode migrating drugs

Country Status (2)

Country Link
AU (1) AU7454598A (en)
WO (1) WO1998055149A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001081103A (en) * 1999-09-13 2001-03-27 Denki Kagaku Kogyo Kk Hyaluronic acid-bound medicinal agent
WO2009049378A1 (en) * 2007-10-17 2009-04-23 Qbiotics Limited Lactone derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2604930B2 (en) * 1990-12-14 1997-04-30 株式会社ディ・ディ・エス研究所 Hyaluronic acid and chondroitin derivatives
JP2527885B2 (en) * 1992-09-02 1996-08-28 株式会社ディ・ディ・エス研究所 Heparin derivatives
JP3001381B2 (en) * 1994-09-16 2000-01-24 株式会社ディ・ディ・エス研究所 Polysaccharide derivative and drug carrier having organ transferability

Also Published As

Publication number Publication date
WO1998055149A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
PL328399A1 (en) Drug administration aid
AU2109195A (en) Two-component device for the administration of drugs
AU7166698A (en) Internal magnetic device to enhance drug therapy
AU5652098A (en) A device for the administration of a liquid medicament suspension
FI972292A0 (en) Administration of diabetes
IL131259A0 (en) Topical drug preparations
AU5945296A (en) Medicament for nasal administration
AU5263496A (en) Targeted catheter drug administration
NO20001219D0 (en) Mixture for drug administration
AU6229696A (en) Novel heteroaromatic piperazines for use as drugs
EP0941039A4 (en) Transdermal administration of ment
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
PL314637A1 (en) Adjuvant drug with derivatives of paklitaxel
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
ATA159197A (en) PHARMACEUTICAL PREPARATION CONTAINING VITAMIN K-DEPENDENT INDIVIDUAL FACTORS
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
AU2559995A (en) Transdermal delivery of anti-epileptic drugs
GB9700737D0 (en) Administration of drugs
AU6940998A (en) Phospholipid drug derivatives
PL321630A1 (en) Application of melantonine for treting patients suffering from drug dependence
AU7454598A (en) Use of drug carriers for producing lymphnode migrating drugs
AU8817398A (en) Method of drug selection
AU4362097A (en) Syringe for medicinal purposes
GB9524942D0 (en) Drug therapy
AU5951798A (en) Oral application of (+)-O-demethyltramadol as a pain- killing drug

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase